It also helps push on the sides of the stomach, which signals our brains natural GLP-1 hormone and makes us feel full
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers
The price does not rise as your dose increases, and there are no hidden charges
Retatrutide Clinical Evidence Context Retatrutide has the strongest evidence in obesity, with Phase 3 data now available in obesity without diabetes, obesity with knee osteoarthritis, and type 2 diabetes
The Gut Microbiome Gut health connects intimately with everything from digestion to nutrient breakdown to weight management
Mounjaro, containing tirzepatide, is approved for diabetes management but is frequently prescribed off-label for chronic weight management